India increasingly emerges as a preferred destination for outsourcing clinical trials - testing of new drugs on humans with the cost of conducting trials in India being 20% to 60% of the cost in industrialized countries. While the market value of clinical trial research outsourced to India is presently estimated at $300 million, having increased by 65% in 2006 alone, the value is expected to become $1.5-2 billion by 2010. .Factors such as a diverse genetic pool, large patient pool, drug-naive population, competent medical professionals, and high-quality hospitals where trials can be undertaken, low cost of services have stimulated the increased flow of clinical research in India.